2-(1-benzofuran-2-yl)-5-bromo-1H-indole | 1218792-36-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 2-(1-benzofuran-2-yl)-5-bromo-1H-indole
• 英文别名: 2-(benzofuran-2-yl)-5-bromo-1H-indole；2-benzofuran-2-yl-5-bromo-1H-indole
• CAS: 1218792-36-9
• 化学式: C₁₆H₁₀BrNO
• 分子量: 312.166
• InChiKey: SHYWSTJJGNONED-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  28.9
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(1-benzofuran-2-yl)-5-bromo-1H-indole 在 铜 正丁基锂 、 potassium carbonate 、 溶剂黄146 作用下， 以 乙醚 、 正己烷 为溶剂， 生成 12-phenyl-3-triphenylsilyl-12H-benzofuranyl[2,3-a]carbazole
  参考文献：
  名称：

  [EN] SUBSTITUTED CARBAZOLE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTRONICS
  [FR] DÉRIVÉS DE CARBAZOLE SUBSTITUÉS ET LEUR UTILISATION EN ÉLECTRONIQUE ORGANIQUE

  摘要：

  一种有机发光二极管、有机太阳能电池或开关元件，包括至少一种取代咔唑衍生物，其通用公式为(I)、(II)或(III)，其中X是NR4、O、S或PR4；Y是NR5、O、S或PR5；其中符号X和Y中至少一个是NR4或NR5；R1和R3各自独立地是取代或未取代的C1-C20-烷基，取代或未取代的C6-C30-芳基，取代或未取代的含有5到30个环原子的杂芳基，或选自C1-C20-烷氧基、C6-C30-芳氧基、C1-C20-烷硫基、C6-C30-芳硫基、SiR6R7R8、卤素自由基、卤代C1-C20-烷基自由基、羰基(-CO(R6))、硫羰基(-C=S(R6))、羰氧基(-C=O(OR6))、氧羰基(-OC=O(R6))、硫羰基(-SC=O(R6))、氨基(-NR6R7)、OH、拟卤素自由基、酰胺(-C=O(NR6))、-NR6C=O(R7)、磷酰基(-P(O)(OR6)2)、磷酸酯(-OP(O)(OR6)2)、膦(-PR6R7)、氧化膦(-P(O)R62)、硫酸酯(-OS(O)2OR6)、亚磺酰基(-S(O)R6)、磺酸酯(-S(O)2OR6)、磺酰基(-S(O)2R6)、磺酰胺(-S(O)2NR6R7)、N02、硼酸酯(-OB(OR6)2)、亚胺(-C=NR6R7)、硼烷自由基、锡烷自由基、肼自由基、腙自由基、肟自由基、亚硝基团、重氮基团、乙烯基团、亚磺酰亚胺、铝烷、锗烷、硼氧基和硼唑的取代基。

  公开号：

  WO2011125020A1
• 作为产物：
  描述：

  (1-benzofuran-2-yl)ethan-2-one (4-bromophenyl)hydrazone 在 zinc(II) chloride 作用下， 以 乙腈 为溶剂， 反应 6.0h， 以70%的产率得到2-(1-benzofuran-2-yl)-5-bromo-1H-indole
  参考文献：
  名称：

  Goudarshivannanavar; Jayadevappa; Mahadevan, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 10, p. 1419 - 1423

  摘要：

  DOI：

文献信息

• SUBSTITUTED CARBAZOLE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTRONICS
  申请人：Langer Nicolle

  公开号：US20110266528A1

  公开（公告）日：2011-11-03

  An organic light-emitting diode, organic solar cell or switching element comprising at least one substituted carbazole derivative of the general formula (I), (II) or (III) in which X is NR 4 , O, S or PR 4 ; Y is NR 5 , O, S or PR 5 ; where at least one of the symbols X and Y is NR 4 or NR 5 ; substituted carbazole derivatives of the formula (I), (II) or (III); a light-emitting layer comprising at least one substituted carbazole derivative of the general formula (I), (II) or (III) and at least one emitter material; the use of substituted carbazole derivatives of the general formula (I), (II) or (Ill) as matrix material, hole/exciton blocker material and/or electron/exciton blocker material and/or hole injection material and/or electron injection material and/or hole conductor material and/or electron conductor material in an organic light-emitting diode, an organic solar cell or in a switching element, and a device selected from the group consisting of stationary visual display units, mobile visual display units, illumination units, keyboards, garments, furniture and wallpaper comprising at least one inventive organic light-emitting diode.

  一种有机发光二极管、有机太阳能电池或开关元件，包括至少一种通式（I）、（II）或（III）的取代咔唑衍生物，其中X为NR4、O、S或PR4；Y为NR5、O、S或PR5；其中至少一个符号X和Y为NR4或NR5；通式（I）、（II）或（III）的取代咔唑衍生物；包括至少一种通式（I）、（II）或（III）的取代咔唑衍生物和至少一种发射材料的发光层；使用通式（I）、（II）或（III）的取代咔唑衍生物作为基质材料、空穴/激子阻挡材料和/或电子/激子阻挡材料和/或空穴注入材料和/或电子注入材料和/或空穴导体材料和/或电子导体材料在有机发光二极管、有机太阳能电池或开关元件中的使用，以及选自固定视觉显示单元、移动视觉显示单元、照明单元、键盘、服装、家具和包括至少一种创新有机发光二极管的壁纸的设备。
• Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections
  作者：Nag S. Kumar、Edie M. Dullaghan、B. Brett Finlay、Huansheng Gong、Neil E. Reiner、J. Jon Paul Selvam、Lisa M. Thorson、Sara Campbell、Nicholas Vitko、Anthony R. Richardson、Roya Zoraghi、Robert N. Young

  DOI：10.1016/j.bmc.2014.01.020

  日期：2014.3

  A novel series of bis-indoles derived from naturally occurring marine alkaloid 4 were synthesized and evaluated as inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase (PK). PK is not only critical for bacterial survival which would make it a target for development of novel antibiotics, but it is reported to be one of the most highly connected 'hub proteins' in MRSA, and thus should be very sensitive to mutations and making it difficult for the bacteria to develop resistance. From the co-crystal structure of cis-3-4-dihydrohamacanthin B (4) bound to S. aureus PK we were able to identify the pharmacophore needed for activity. Consequently, we prepared simple direct linked bis-indoles such as 10b that have similar anti-MRSA activity as compound 4. Structure-activity relationship (SAR) studies were carried out on 10b and led us to discover more potent compounds such as 10c, 10d, 10k and 10m with enzyme inhibiting activities in the low nanomolar range that effectively inhibited the bacteria growth in culture with minimum inhibitory concentrations (MIC) for MRSA as low as 0.5 mu g/ml. Some potent PK inhibitors, such as 10b, exhibited attenuated antibacterial activity and were found to be substrates for an efflux mechanism in S. aureus. Studies comparing a wild type S. aureus with a construct (S. aureus LAC Delta pyk::ErmR) that lacks PK activity confirmed that bactericidal activity of 10d was PK-dependant. (C) 2014 Elsevier Ltd. All rights reserved.
• ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS
  申请人：SIMON FRASER UNIVERSITY

  公开号：US20170216252A1

  公开（公告）日：2017-08-03

  Compounds of general formula I that are capable of inhibiting bacterial pyruvate kinase and/or bacterial growth. The compounds may find use as antibacterial agents in therapeutic and/or non-therapeutic contexts.
• US8637857B2
  申请人：——

  公开号：US8637857B2

  公开（公告）日：2014-01-28
• [EN] ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS<br/>[FR] COMPOSÉS ANTIBACTÉRIENS MODULATEURS DE LA PYRUVATE KINASE, COMPOSITIONS, UTILISATIONS ET PROCÉDÉS ASSOCIÉS
  申请人：UNIV FRASER SIMON

  公开号：WO2016004513A1

  公开（公告）日：2016-01-14

  Compounds of general formula I that are capable of inhibiting bacterial pyruvate kinase and/or bacterial growth. The compounds may find use as antibacterial agents in therapeutic and/or non- therapeutic contexts.